CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Company Snapshot
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Zhong Xin Pharmaceutical Group Corporation Limited with three other companies in this sector in China: Zhejiang Medicine Co., Ltd. (2017 sales of 5.69 billion Chinese Renmimbi [US$824.06 million] of which 43% was Life Nourishment), Hubei Jumpcan Pharmaceutical Co Ltd (5.64 billion Chinese Renmimbi [US$816.74 million] of which 96% was Industrial), and Northeast Pharmaceutical Group Co., Ltd. (5.68 billion Chinese Renmimbi [US$821.71 million] of which 64% was Pharmaceutical Products).

Sales Analysis. During the year ended December of 2017, sales at Tianjin Zhong Xin Pharmaceutical Group Corporation Limited were 5.69 billion Chinese Renmimbi (US$823.57 million). This is a decrease of 7.9% versus 2016, when the company's sales were 6.18 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 10.3% decline in Chinese Medicine, from 4.07 billion Chinese Renmimbi to 3.65 billion Chinese Renmimbi. There were also decreases in sales in Western Medicine (down 9.1% to 1.49 billion Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Others (up 16.5% to 549.48 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
  Stock Performance Chart for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (12/14/2018): 13.06
(Figures in Chinese Renmimbi)
1 Week -6.4%   13 Weeks -10.9%  
4 Weeks -11.8%   52 Weeks -18.3%  
 
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Key Data:
  Ticker: 600329 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 5,689,242,000
(Year Ending Jan 2018).
Employees: 4,274
  Currency: Chinese Renmimbi Market Cap: 10,041,482,373
  Fiscal Yr Ends: December Shares Outstanding: 768,873,076
  Share Type: A Gu Closely Held Shares: 344,096,657
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.